Covaxin Maker Bharat Biotech’s Nasal Booster Dose Trials Get Approval
The Drug Controller Common of India nowadays gave the go-ahead for the Segment-III trials New Delhi: Vaccine producer Bharat Biotech
Read MoreThe Drug Controller Common of India nowadays gave the go-ahead for the Segment-III trials New Delhi: Vaccine producer Bharat Biotech
Read MoreThe corporate stated closing week it had proven 81% efficacy in combating symptomatic COVID-19. Bengaluru: A COVID-19 vaccine evolved by
Read MoreHow did you get into the vaccine industry? Once I started conceptualising a Hepatitis vaccine, I used to be operating
Read MoreWritten via Kaunain Sheriff M | New Delhi | December 8, 2020 2:06:28 am Each govt and personal healthcare amenities
Read More